학술논문
Efficacy and safety of canakinumab as a second line biologic after tocilizumab treatment failure in children with systemic juvenile idiopathic arthritis: A single-centre cohort study using routinely collected health data
Document Type
Article
Author
Source
In: Frontiers in Pediatrics . (Frontiers in Pediatrics, 21 February 2023, 11)
Subject
Language
English
ISSN
22962360